MS Therapy Management for Pregnancy May Raise Relapse Risk

(MedPage Today) — Management of disease-modifying therapies (DMTs) for multiple sclerosis (MS) during pregnancy raised relapse risk, especially for certain drugs, French registry data suggested.
Across all MS drugs, DMT management during pregnancy…

Source link : https://www.medpagetoday.com/neurology/multiplesclerosis/116818

Author :

Publish date : 2025-08-04 19:13:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

MS Therapy Management for Pregnancy May Raise Relapse Risk

Fewer Ocular Pressure Spikes With Drug Vials vs Popular Prefilled Syringes

A White House Pandemic Office Is Being Sidelined. Here’s Why That Matters

Related Posts

Did FDA Pick the Wrong COVID Vaccine Strain Last Season?

Tamiflu Findings Raise Questions About Drug Label Warning for Kids

Weight Loss Diet Not Needed With Exercise for Hip OA Pain

Low-Cal Diet Plus Exercise May Help Patients With Hip OA

Nearly 17M U.S. Teens, Young Adults Eligible for GLP-1 Agonists

Novel T1D Therapy Opens the Door to Cell Transplants Sans Immunosuppressants

Did FDA Pick the Wrong COVID Vaccine Strain Last Season?

Tamiflu Findings Raise Questions About Drug Label Warning for Kids

Weight Loss Diet Not Needed With Exercise for Hip OA Pain

Low-Cal Diet Plus Exercise May Help Patients With Hip OA

Nearly 17M U.S. Teens, Young Adults Eligible for GLP-1 Agonists

Novel T1D Therapy Opens the Door to Cell Transplants Sans Immunosuppressants

A White House Pandemic Office Is Being Sidelined. Here’s Why That Matters

MS Therapy Management for Pregnancy May Raise Relapse Risk

Categories

Archives